4.5 Article

Synthesis and physicochemical characterization of Zn-Al layered double hydroxides (LDHs) as a delivery system for amphotericin B: In vitro and in silico antileishmanial study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(R)) in Cutaneous Leishmaniasis

Aishah E. Albalawi et al.

Summary: This study demonstrated the potential of copper nanoparticles green synthesized by Capparis spinosa fruit extract in treating leishmaniasis, especially when combined with meglumine antimoniate. The nanoparticles significantly reduced parasite numbers and lesion diameters in animal experiments. This treatment approach shows promise for improving clinical outcomes in leishmaniasis.

NANOMATERIALS (2021)

Article Biochemistry & Molecular Biology

Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis

Fernanda V. Cabral et al.

Summary: The study demonstrates that topical application of 2 mM NONPs can effectively reduce parasite burden and lesion thickness in mice with cutaneous leishmaniasis, showing visible signs of clinical healing without ulceration. This successful outcome can last for at least 21 days even after a single dose of therapy.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2021)

Review Public, Environmental & Occupational Health

Nanoparticles: New agents toward treatment of leishmaniasis

Amir Nafari et al.

PARASITE EPIDEMIOLOGY AND CONTROL (2020)

Review Medicine, General & Internal

Review of Leishmaniasis in the Middle East and North Africa

Ahmed Tabbabi

AFRICAN HEALTH SCIENCES (2019)

Review Parasitology

Application of nanotechnology in treatment of leishmaniasis: A Review

Maryam Akbari et al.

ACTA TROPICA (2017)

Article Public, Environmental & Occupational Health

Three Leishmania/L. species - L-infantum, L-major, L-tropica - as causative agents of mucosal leishmaniasis in Iran

Sadegh Shirian et al.

PATHOGENS AND GLOBAL HEALTH (2013)

Article Multidisciplinary Sciences

Leishmaniasis Worldwide and Global Estimates of Its Incidence

Jorge Alvar et al.

PLOS ONE (2012)

Review Health Care Sciences & Services

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

Viroj Wiwanitkit

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2012)

Review Microbiology

Leishmaniasis: complexity at the host-pathogen interface

Paul Kaye et al.

NATURE REVIEWS MICROBIOLOGY (2011)

Article Public, Environmental & Occupational Health

Cross-protection against Leishmania donovani but not L-braziliensis caused by vaccination with L-major soluble promastigote exogenous antigens in BALB/c mice

Willy K. Tonui et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)